Date
21 January 2026Location
Online via Webex at 13:00 – 14:00About the event
This drop-in session was developed in light of the prevention of future deaths report and the MHRA letter to MS licence holders for aseptic operations.
Why it’s important
Understanding objectionable microorganisms and how to respond effectively is essential for maintaining product quality and patient safety. This session helped attendees understand:
- which microorganisms are objectionable and why
- the challenges associated with Bacillus cereus and related species
- how to respond appropriately when objectionable microorganisms are identified
- key factors that influence investigations, the contamination control strategy and the training and supervision of staff members
Intended audience
The session was suitable for:
- aseptic services and radiopharmacy services teams
- QA/QC managers and deputies
- authorised and accountable pharmacists
Speakers
The session included a presentation and Q&As session.
Register
Registration is now closed.
Note: Our Quality Assurance webinars are provided for NHS colleagues so please register with your NHS email address.
Resources
The live Q&As is an opportunity during the webinar only. Our pre-recorded presentations are available on our quality assurance for aseptic services videos page and our temperature management for medicines storage video page.
Check your access before the event
Check that you are able to access WebEx prior to the event.
We recommend installing the Cisco WebEx app, or, alternatively, accessing the meeting via Google Chrome. If you are still having difficulty, you may need to contact your IT department to assist you in opening the application (you’ll only have to do this once).
Contact us
Please contact the QA team if you have any questions.
Update history
- Now a past event
- Published